Indication
Influenza due to influenza virus type A
Influenza due to influenza virus type A is an acute, contagious viral infection that primarily affects the respiratory system, including the upper and lower respiratory tracts. Read more about Influenza due to influenza virus type A
4 drugs 3 manufacturers
Drugs that treat it
Common Influenza due to influenza virus type A therapies.
RAPIVAB (peramivir/PF)
RAPIVAB (PF) (peramivir/PF)
RAPIVAB (peramivir/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonInfluenza due to influenza virus type A is an acute, contagious viral infection that primarily affects the respiratory system, including the upper and lower respiratory tracts.
It is caused by an enveloped, negative-sense, single-stranded RNA orthomyxovirus categorized into subtypes based on the antigenic properties of its surface glycoproteins, hemagglutinin and neuraminidase.
Pathophysiologically, the virus infects and replicates within respiratory epithelial cells, triggering localized mucosal inflammation and a robust systemic inflammatory cytokine response.
Clinically, it manifests with the abrupt onset of systemic symptoms—such as high fevers, chills, myalgias, severe fatigue, and headaches—often accompanied by cough, sore throat, and nasal congestion, with potential progression to severe primary viral pneumonia or secondary bacterial infections in vulnerable populations.
- nih.gov
Influenza due to influenza virus type A is an acute, contagious viral infection that primarily affects the respiratory system, including the upper and lower respiratory tracts
- nih.gov
Influenza due to influenza virus type A is an acute, contagious viral infection that primarily affects the respiratory system, including the upper and lower respiratory tracts Pathophysiologically, the virus infects and replicates within respiratory epithelial cells, triggering localized mucosal inflammation and a robust systemic inflammatory cytokine response
- cdc.gov
It is caused by an enveloped, negative-sense, single-stranded RNA orthomyxovirus categorized into subtypes based on the antigenic properties of its surface glycoproteins, hemagglutinin and neuraminidase
- nih.gov
It is caused by an enveloped, negative-sense, single-stranded RNA orthomyxovirus categorized into subtypes based on the antigenic properties of its surface glycoproteins, hemagglutinin and neuraminidase Clinically, it manifests with the abrupt onset of systemic symptoms—such as high fevers, chills, myalgias, severe fatigue, and headaches—often accompanied by cough, sore throat, and nasal congestion, with potential progression to severe primary viral pneumonia or secondary bacterial infections in...
- cdc.gov
Pathophysiologically, the virus infects and replicates within respiratory epithelial cells, triggering localized mucosal inflammation and a robust systemic inflammatory cytokine response Clinically, it manifests with the abrupt onset of systemic symptoms—such as high fevers, chills, myalgias, severe fatigue, and headaches—often accompanied by cough, sore throat, and nasal congestion, with potential progression to severe primary viral pneumonia or secondary bacterial infections in vulnerable popu...
Personalize your experience
Follow Influenza due to influenza virus type A and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.